| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |